Victor C. W. Chan

Victor C. W. Chan

Auto-generated profile, based on publicly available information

Victor C. W. Chan

Institute of Digestive Disease, Chinese University of Hong Kong, Shatin, Hong Kong, HKSAR, China

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2016 in Inflammatory Bowel Diseases
Verified
Journal Article
Closed access
PDF file
SNSiew C. Ng
Siew C. Ng
WLWai K Leung
Wai K Leung
HSHai Yun Shi
Hai Yun Shi
MLMichael K. K. Li
Michael K. K. Li
CLChi Man Leung
Chi Man Leung
JSJoseph JY Sung
Joseph JY Sung
Background. Incidence of inflammatory bowel disease (IBD) is increasing in Asia, but population-based prevalence data are limited. This study examined IBD inci

1 January 2016 in Gastroenterology
Verified
Journal Article
Closed access
PDF file
SNSiew C Ng
Siew C Ng
ZZZhirong Zeng
Zhirong Zeng
ONOla Niewiadomski
Ola Niewiadomski
WTWhitney Tang
Whitney Tang
SBSally Bell
Sally Bell
JSJoseph JY Sung
Joseph JY Sung

17 September 2013 in Gut
Verified
Journal Article
Closed access
PDF file
Martin WongMartin Wong
Martin Wong
TLThomas Y T Lam
Thomas Y T Lam
KTKelvin K F Tsoi
Kelvin K F Tsoi
HHHoyee W Hirai
Hoyee W Hirai
VCVictor C W Chan
Victor C W Chan
JSJoseph JY Sung
Joseph JY Sung
Objective We aim to develop and validate a clinical scoring system to predict the risks of colorectal neoplasia to better inform screening participants and facilitate their screening test choice. Design We recruited 5220 Chinese asymptomatic screening participants who underwent colonoscopy in Hong Kong during 2008–2012. From random sampling of 2000 participants, independent risk factors were evaluated for colorectal neoplasia, defined as adenoma, advanced neoplasia, colorectal cancer or any combination thereof using binary regression analysis. The ORs for significant risk factors were used to develop a scoring system ranging from 0 to 6: 0–2 ‘average risk’ (AR) and 3–6 ‘high risk’ (HR). The other 3220 screening participants prospectively enrolled between 2008 and 2012 for screening colonoscopy formed an independent validation cohort. The performance of the scoring system for predicting colorectal neoplasia was evaluated. Results The prevalence of colorectal neoplasia in the derivation and validation cohorts was 31.4% and 30.8%, respectively. Using the scoring system developed, 78.9% and 21.1% in the validation cohort were classified as AR and HR, respectively. The prevalence of colorectal neoplasia in the AR and HR groups was 27.1% and 44.6%, respectively. The subjects in the HR group had 1.65-fold (95% CI 1.49 to 1.83) increased prevalence of colorectal neoplasia than the AR group. Conclusions The scoring system based on age, gender, smoking, family history, Body Mass Index and self-reported diabetes is useful in predicting the risk of colorectal neoplasia.

28 December 2017 in Journal of Gastroenterology and Hepatology
Verified
Journal Article
Closed access
PDF file
JSJoseph JY Sung
Joseph JY Sung
Martin WongMartin Wong
Martin Wong
TLThomas Y T Lam
Thomas Y T Lam
KTKelvin K F Tsoi
Kelvin K F Tsoi
VCVictor C W Chan
Victor C W Chan
JCJessica Y L Ching
Jessica Y L Ching

1 August 2015 in Clinical Gastroenterology and Hepatology
Verified
Journal Article
Closed access
Martin WongMartin Wong
Martin Wong
JCJessica Y.L. Ching
Jessica Y.L. Ching
VCVictor C.W. Chan
Victor C.W. Chan
TLThomas Y.T. Lam
Thomas Y.T. Lam
JSJeffrey P. Shum
Jeffrey P. Shum
JSJoseph JY Sung
Joseph JY Sung

1 March 2015 in Gastrointestinal Endoscopy
Verified
Journal Article
Closed access
Martin WongMartin Wong
Martin Wong
JCJessica Y.L. Ching
Jessica Y.L. Ching
VCVictor C.W. Chan
Victor C.W. Chan
TLThomas Y.T. Lam
Thomas Y.T. Lam
ALArthur K.C. Luk
Arthur K.C. Luk
JSJoseph JY Sung
Joseph JY Sung